Which has preferable earnings and valuation, ILMN or QGEN?

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 5.79 $850M $5.50 30.22 Qiagen $2.09B 3.69 $424.88M $1.91 19.57

Is ILMN or QGEN more profitable?

Illumina has a net margin of 19.42% compared to Qiagen's net margin of 19.16%. Illumina's return on equity of 31.01% beat Qiagen's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 19.42% 31.01% 12.22% Qiagen 19.16% 14.40% 8.40%

Does the media favor ILMN or QGEN?

In the previous week, Illumina had 20 more articles in the media than Qiagen. MarketBeat recorded 22 mentions for Illumina and 2 mentions for Qiagen. Illumina's average media sentiment score of 1.17 beat Qiagen's score of 0.90 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Qiagen 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ILMN or TMO?

In the previous week, Thermo Fisher Scientific had 19 more articles in the media than Illumina. MarketBeat recorded 41 mentions for Thermo Fisher Scientific and 22 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.39 beat Illumina's score of 1.17 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 37 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer A or ILMN?

In the previous week, Illumina had 3 more articles in the media than Agilent Technologies. MarketBeat recorded 22 mentions for Illumina and 19 mentions for Agilent Technologies. Illumina's average media sentiment score of 1.17 beat Agilent Technologies' score of 1.10 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ILMN or WAT?

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 5.79 $850M $5.50 30.22 Waters $3.17B 11.16 $642.63M $7.87 45.72

Is ILMN or WAT more profitable?

Illumina has a net margin of 19.42% compared to Waters' net margin of 11.91%. Illumina's return on equity of 31.01% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Illumina 19.42% 31.01% 12.22% Waters 11.91% 15.60% 8.90%

Does the media favor ILMN or WAT?

In the previous week, Illumina had 12 more articles in the media than Waters. MarketBeat recorded 22 mentions for Illumina and 10 mentions for Waters. Illumina's average media sentiment score of 1.17 beat Waters' score of 1.09 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Waters 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ILMN or MTD?

In the previous week, Illumina had 20 more articles in the media than Mettler-Toledo International. MarketBeat recorded 22 mentions for Illumina and 2 mentions for Mettler-Toledo International. Illumina's average media sentiment score of 1.17 beat Mettler-Toledo International's score of 0.35 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Illumina (ILMN) Competitors

$166.21 +3.74 (+2.30%)

Closing price 04:00 PM Eastern

Extended Trading

$164.24 -1.97 (-1.18%)

As of 07:52 PM Eastern

Compare

ILMN vs. QGEN, TMO, A, WAT, and MTD

Should you buy Illumina stock or one of its competitors? MarketBeat compares Illumina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Illumina include Qiagen (QGEN), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Waters (WAT), and Mettler-Toledo International (MTD). These companies are all part of the "medical" sector.

How does Illumina compare to Qiagen?

Illumina (NASDAQ:ILMN) and Qiagen (NYSE:QGEN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

Illumina has a net margin of 19.42% compared to Qiagen's net margin of 19.16%. Illumina's return on equity of 31.01% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Qiagen	19.16%	14.40%	8.40%

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	5.79	$850M	$5.50	30.22
Qiagen	$2.09B	3.69	$424.88M	$1.91	19.57

89.4% of Illumina shares are owned by institutional investors. Comparatively, 70.0% of Qiagen shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Comparatively, 9.0% of Qiagen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Illumina has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market. Comparatively, Qiagen has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market.

Illumina presently has a consensus target price of $142.13, suggesting a potential downside of 14.49%. Qiagen has a consensus target price of $44.98, suggesting a potential upside of 20.32%. Given Qiagen's stronger consensus rating and higher possible upside, analysts clearly believe Qiagen is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.33
Qiagen	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

In the previous week, Illumina had 20 more articles in the media than Qiagen. MarketBeat recorded 22 mentions for Illumina and 2 mentions for Qiagen. Illumina's average media sentiment score of 1.17 beat Qiagen's score of 0.90 indicating that Illumina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Qiagen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Illumina beats Qiagen on 13 of the 17 factors compared between the two stocks.

How does Illumina compare to Thermo Fisher Scientific?

Illumina (NASDAQ:ILMN) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	5.79	$850M	$5.50	30.22
Thermo Fisher Scientific	$44.56B	3.96	$6.70B	$18.19	26.12

89.4% of Illumina shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 2.9% of Illumina shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 19 more articles in the media than Illumina. MarketBeat recorded 41 mentions for Thermo Fisher Scientific and 22 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.39 beat Illumina's score of 1.17 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	37 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Illumina has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Illumina has a net margin of 19.42% compared to Thermo Fisher Scientific's net margin of 15.15%. Illumina's return on equity of 31.01% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Thermo Fisher Scientific	15.15%	16.86%	8.15%

Illumina currently has a consensus target price of $142.13, indicating a potential downside of 14.49%. Thermo Fisher Scientific has a consensus target price of $608.95, indicating a potential upside of 28.17%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.33
Thermo Fisher Scientific	0 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.88

Summary

Thermo Fisher Scientific beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

In the previous week, Illumina had 3 more articles in the media than Agilent Technologies. MarketBeat recorded 22 mentions for Illumina and 19 mentions for Agilent Technologies. Illumina's average media sentiment score of 1.17 beat Agilent Technologies' score of 1.10 indicating that Illumina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has a net margin of 19.55% compared to Illumina's net margin of 19.42%. Illumina's return on equity of 31.01% beat Agilent Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Illumina	19.42%	31.01%	12.22%

89.4% of Illumina shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Agilent Technologies has higher revenue and earnings than Illumina. Agilent Technologies is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	5.26	$1.30B	$4.98	25.98
Illumina	$4.34B	5.79	$850M	$5.50	30.22

Agilent Technologies has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Illumina has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

Agilent Technologies presently has a consensus target price of $160.93, indicating a potential upside of 24.40%. Illumina has a consensus target price of $142.13, indicating a potential downside of 14.49%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Agilent Technologies is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88
Illumina	2 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Illumina beats Agilent Technologies on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Waters?

Illumina (NASDAQ:ILMN) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Illumina presently has a consensus price target of $142.13, indicating a potential downside of 14.49%. Waters has a consensus price target of $394.56, indicating a potential upside of 9.66%. Given Waters' stronger consensus rating and higher possible upside, analysts clearly believe Waters is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.33
Waters	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.71

In the previous week, Illumina had 12 more articles in the media than Waters. MarketBeat recorded 22 mentions for Illumina and 10 mentions for Waters. Illumina's average media sentiment score of 1.17 beat Waters' score of 1.09 indicating that Illumina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Illumina has a net margin of 19.42% compared to Waters' net margin of 11.91%. Illumina's return on equity of 31.01% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Waters	11.91%	15.60%	8.90%

Illumina has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market. Comparatively, Waters has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	5.79	$850M	$5.50	30.22
Waters	$3.17B	11.16	$642.63M	$7.87	45.72

89.4% of Illumina shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 2.9% of Illumina shares are held by insiders. Comparatively, 0.3% of Waters shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Illumina beats Waters on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Mettler-Toledo International?

Illumina (NASDAQ:ILMN) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

In the previous week, Illumina had 20 more articles in the media than Mettler-Toledo International. MarketBeat recorded 22 mentions for Illumina and 2 mentions for Mettler-Toledo International. Illumina's average media sentiment score of 1.17 beat Mettler-Toledo International's score of 0.35 indicating that Illumina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

89.4% of Illumina shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 2.9% of Illumina shares are held by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Mettler-Toledo International has lower revenue, but higher earnings than Illumina. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	5.79	$850M	$5.50	30.22
Mettler-Toledo International	$4.03B	5.72	$869.19M	$42.64	26.71

Mettler-Toledo International has a net margin of 21.40% compared to Illumina's net margin of 19.42%. Illumina's return on equity of 31.01% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Mettler-Toledo International	21.40%	-622.80%	24.97%

Illumina has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Illumina presently has a consensus price target of $142.13, indicating a potential downside of 14.49%. Mettler-Toledo International has a consensus price target of $1,408.55, indicating a potential upside of 23.69%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts clearly believe Mettler-Toledo International is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.33
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Summary

Illumina beats Mettler-Toledo International on 9 of the 16 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ILMN vs. The Competition

Export

Metric	Illumina	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$24.58B	$3.29B	$6.47B	$11.73B
Dividend Yield	N/A	2.33%	2.67%	5.56%
P/E Ratio	30.22	19.62	24.43	24.33
Price / Sales	5.79	301.53	503.67	108.33
Price / Cash	24.20	120.36	43.20	54.62
Price / Book	9.33	8.21	10.50	6.82
Net Income	$850M	$23.89M	$3.56B	$337.41M
7 Day Performance	-1.10%	-3.00%	-2.02%	-0.96%
1 Month Performance	16.63%	-1.64%	0.66%	1.68%
1 Year Performance	89.87%	40.20%	21.85%	26.88%

Illumina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ILMN Illumina	2.2267 of 5 stars	$166.21 +2.3%	$142.13 -14.5%	+84.7%	$24.58B	$4.34B	30.22	8,650	Positive News Analyst Upgrade Insider Trade
QGEN Qiagen	4.6914 of 5 stars	$35.72 -1.3%	$44.98 +25.9%	-23.9%	$7.46B	$2.09B	18.65	5,654	Short Interest Decrease
TMO Thermo Fisher Scientific	4.8905 of 5 stars	$480.62 -2.7%	$612.24 +27.4%	+16.5%	$183.60B	$44.56B	26.42	125,000	Positive News Analyst Forecast
A Agilent Technologies	4.9703 of 5 stars	$135.03 -0.7%	$162.79 +20.6%	+9.2%	$38.43B	$6.95B	27.12	18,100	Positive News Analyst Forecast
WAT Waters	2.8287 of 5 stars	$371.90 -1.7%	$395.71 +6.4%	+4.1%	$37.13B	$3.17B	47.25	7,900	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ILMN) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Illumina (ILMN) Competitors

ILMN vs. QGEN, TMO, A, WAT, and MTD

How does Illumina compare to Qiagen?

Summary

How does Illumina compare to Thermo Fisher Scientific?

Summary

How does Illumina compare to Agilent Technologies?

Summary

How does Illumina compare to Waters?

Summary

How does Illumina compare to Mettler-Toledo International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN vs. The Competition

Illumina Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Illumina (ILMN) Competitors

ILMN vs. QGEN, TMO, A, WAT, and MTD

How does Illumina compare to Qiagen?

Is ILMN or QGEN more profitable?

Which has preferable earnings and valuation, ILMN or QGEN?

Do institutionals & insiders hold more shares of ILMN or QGEN?

Which has more risk & volatility, ILMN or QGEN?

Do analysts recommend ILMN or QGEN?

Does the media favor ILMN or QGEN?

Summary

How does Illumina compare to Thermo Fisher Scientific?

Which has higher valuation and earnings, ILMN or TMO?

Do insiders and institutionals hold more shares of ILMN or TMO?

Does the media refer more to ILMN or TMO?

Which has more risk & volatility, ILMN or TMO?

Is ILMN or TMO more profitable?

Do analysts prefer ILMN or TMO?

Summary

How does Illumina compare to Agilent Technologies?

Does the media prefer A or ILMN?

Is A or ILMN more profitable?

Do institutionals and insiders believe in A or ILMN?

Which has better valuation and earnings, A or ILMN?

Which has more volatility & risk, A or ILMN?

Do analysts recommend A or ILMN?

Summary

How does Illumina compare to Waters?

Do analysts rate ILMN or WAT?

Does the media favor ILMN or WAT?

Is ILMN or WAT more profitable?

Which has more risk & volatility, ILMN or WAT?

Which has preferable valuation and earnings, ILMN or WAT?

Do insiders and institutionals believe in ILMN or WAT?

Summary

How does Illumina compare to Mettler-Toledo International?

Does the media refer more to ILMN or MTD?

Do institutionals and insiders believe in ILMN or MTD?

Which has better valuation & earnings, ILMN or MTD?

Is ILMN or MTD more profitable?

Which has more volatility and risk, ILMN or MTD?

Do analysts rate ILMN or MTD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN vs. The Competition

Illumina Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools